• Skip to primary navigation
  • Skip to main content
  • Skip to footer
IRETA

IRETA

Institute for Research, Education & Training in Addictions

  • myIRETA
  • Contact Us
  • Who We Are
    • Who We Are
    • Our Organization
      • IRETA Staff
      • IRETA Board of Directors
      • Annual Reports & Financials
      • Partners and Clients
      • Staff Publications
      • Employment Opportunities
    • Addiction and Recovery
    • Our Work
  • Consulting
    • IRETA Consulting
    • Performance Evaluation
    • Program Assistance
    • Healthcare Organizations
    • Addiction Treatment Providers
    • Criminal Justice System
  • Education & Training
    • Education & Training
    • Scaife Medical Student Fellowship in Substance Use Disorders
  • Webinars
  • Blog
  • Resource Library
Home / Resources / Medication First: Integration of Opioid Use Disorder Treatment Across the Healthcare System

Medication First: Integration of Opioid Use Disorder Treatment Across the Healthcare System

Written by Jessica Williams | March 22, 2019

**Please note, we do not provide CEUs for viewing recorded webinars. If you are interested in receiving CEUs, you can view and register for our upcoming webinars here.**

Description

In traditional treatment programs for addiction, the majority of patients are not offered ongoing medical treatment. The minority who do receive medical care typically face intensive psychosocial service requirements that make access to medical treatment both burdensome and costly. Others face arbitrary limitations on medical treatment that are associated with increased risk for morbidity and mortality.

Medication First programs get persons with opioid use disorder maintenance medical treatment as quickly as possible and provide voluntary supportive services as needed. A patient’s access to medical treatment is not dependent upon psychosocial treatment compliance or unrealistic expectations about the course of treatment and recovery. The Medication First approach is supported by decades of research. It prioritizes client choice in both service selection and service participation. There is a strong consensus in the scientific community that expanding the Medication First or “low-threshold” medical approach to opioid use disorder will be essential to reversing the epidemic of opioid-related deaths.

Presenter

Ned Presnall, LCSW is executive director of Clayton Behavioral treatment programs in St. Louis, an adjunct professor and senior data analyst at Washington University in St. Louis, and a consultant for Missouri’s State Targeted Response to the Opioid Crisis. He divides his time between clinical work, education, and research.

Additional Resources

Slides

Footer

IRETA

The Institute for Research, Education and Training in Addictions (IRETA) is an independent 501(c)3 nonprofit located in Pittsburgh, PA. Our mission is to help people respond effectively to substance use and related problems.

Contact

611 William Penn Place
Suite 403
Pittsburgh, PA 15219

P: 412-258-8565
F: 412-391-2528

LinkedIn Twitter Facebook YouTube

Copyright © 2023 IRETA